Downbeat retail sales data and Treasury Secretary Scott Bessent's comments are adding to worries about the economy.

The S&P 500 (^GSPC) has entered correction, falling 10% from its February all-time highs as political uncertainty has driven ...

The Federal Reserve will keep interest rates steady through the first half of the year, before delivering two reductions ...

Dollarama (TSE:DOL – Get Free Report) had its target price raised by stock analysts at BMO Capital Markets from C$154.00 to ...

UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...

ECN Capital Corp. (TSX: ECN) ("ECN Capital” or the "Company”) today announced that it has entered into an agreement with a syndicate of underwriters (the "Underwriters”) led by CIBC Capital Markets, ...

Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney ...

On Tuesday, BMO Capital Markets began coverage of Avidity Biosciences (NASDAQ:RNA) shares, assigning an Outperform rating and setting a price target of $72.00. Currently trading at $29.58, the stock ...

The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...